Cogent Biosciences Stock 346% Surge Fueled by New Stake
A Phase 3 breakthrough unleashed a dramatic move in Cogent Biosciences. A large fund followed with a sizable stake, s...
Knowing what to look for when buying dividend stocks can help you make informed choices. Gain key insights to enhance your investments.
18,908 articlesA Phase 3 breakthrough unleashed a dramatic move in Cogent Biosciences. A large fund followed with a sizable stake, s...
A clear, reader-friendly breakdown of Acadia’s Q4 2025 earnings. We unpack revenue trends, pipeline progress, and key...
A recent filing shows Meros Investment Management sold a sizable block of Photronics shares. Learn what this kind of ...
Quantum computing is approaching a pivotal moment. This article lays out why the thesis 'prediction: ionq will first'...
The apei 2026 earnings call offers crucial clues about enrollment momentum, cost discipline, and future guidance. Thi...
Get an in-depth look at Paysafe (PSFE) 2026 earnings outlook. We break down Q1 results, revenue streams, margin trend...
A notable investor doubled down on XPLR Infrastructure after a sharp 42% rise, highlighting the appeal of long-term, ...
IonQ just crossed a historic revenue milestone, signaling a turning point for pure-play quantum investing. This artic...
Many retirees lean on a simple withdrawal rule to fund their golden years. This guide explains why that rule can fail...
A recent FDA decision sparked a powerful rally in Moderna shares, but is the move enough to call it a no-brainer? Thi...
Palantir Technologies has had a wild ride. If you’re wondering should palantir technologies stock be bought under $14...
Structure Therapeutics stock 187% gains over the last year drew attention from value seekers and momentum players ali...